A few days ago, I wrote an article while on a plane. I’m an expat, and I was flying back to my home country. I’m now in my hometown, where I lived until I was 18. I come back here only seldom, and the last time I visited was four years ago. For the vast…

Yet another important investment in the field of regenerative medicine against aging demonstrates the increasing interest of investors in this industry; on August 2, BioTime, Inc. announced that Juvenescence Limited will buy 14.4 million of its subsidiary AgeX Therapeutics‘ shares for a total of $43.2 million—50% to be paid in cash and 50% with a…

We are now starting to release the videos from our July conference, Ending Age-Related Diseases: Investment Prospects & Advances in Research, which was hosted in NYC at Cooper Union. Today, we show Dr. Aubrey de Grey giving his keynote speech at the conference. He begins, as all good speakers should, in a mixed audience of experienced…

As our organization grows and we are doing more and more things, there is an ever greater need for specialist knowledge and guidance to help inform our decisions as a company. We rely on the advice and expertize of both our scientific and business advisors and we have added to them this week with two…

Recently, we’ve published an article explaining why life extension is not a selfish endeavor. As a matter of fact, life extension is a rather altruistic endeavor, though this depends on your interpretation of the definition. Let’s dig deeper. What is altruism? According to the Oxford English Dictionary, altruism is disinterested and selfless concern for the…

This is a fictional story about a man realizing for the first time, under rather unusual circumstances, that he has a deep desire not to age and die. It’s been a few months already, yet that day still feels like yesterday. I am still not convinced that I didn’t lose my mind that day, and…

© 2018 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

       Powered by MMD